Related Experiment Video
Updated: May 3, 2026
09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
26.7K
Overeating phenotypes in overweight and obese children.
Kerri N Boutelle1, Carol B Peterson2, Ross D Crosby3
1Department of Psychiatry, University of California, San Diego, 9500 Gilman Drive, MC 0874, La Jolla, CA 92037, United States; Department of Pediatrics, University of California, San Diego, 9500 Gilman Drive, MC 0874, La Jolla, CA 92037, United States.
Appetite
|February 15, 2014
Summary
This study identified three distinct overeating phenotypes in children with overweight and obesity. These phenotypes, like high food responsiveness, are linked to higher BMI, aiding targeted interventions.
Area of Science:
- Pediatric Obesity Research
- Behavioral Science
- Eating Disorders
Background:
- Overweight and obesity in children are significant public health concerns.
- Understanding the heterogeneity of eating behaviors is crucial for effective interventions.
- Existing research often treats overeating as a monolithic behavior.
Purpose of the Study:
- To identify distinct overeating phenotypes in treatment-seeking overweight and obese children.
- To explore the correlates of these identified phenotypes.
- To inform targeted prevention and treatment strategies for pediatric obesity.
Main Methods:
- Recruited 117 overweight/obese children (8-12 years) and their parents.
- Utilized an eating in the absence of hunger (EAH) paradigm, clinical interviews, and questionnaires.
- Employed latent profile analysis to classify overeating phenotypes.
Main Results:
- Identified three phenotypes: High Satiety Responsive, High Food Responsive, and Moderate Satiety and Food Responsive.
- The High Food Responsive group exhibited significantly higher BMI and BMI-Z scores.
- No significant differences were found in demographics or nutritional intake across phenotypes.
Conclusions:
- Overeating in overweight/obese children is heterogeneous, not a single entity.
- Phenotypes like 'High Food Responsive' may indicate higher obesity risk.
- Findings support personalized approaches for pediatric obesity prevention and treatment.
Related Concept Videos
01:24Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
01:23Binge Eating Disorders
828
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
828
01:30Bulimia Nervosa
1.1K
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
1.1K
01:21Drug Dosing: Obese Patients
368
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
368
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
324
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
324
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
440
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440